1. Home
  2. PRPO vs EMKR Comparison

PRPO vs EMKR Comparison

Compare PRPO & EMKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • EMKR
  • Stock Information
  • Founded
  • PRPO N/A
  • EMKR 1984
  • Country
  • PRPO United States
  • EMKR United States
  • Employees
  • PRPO N/A
  • EMKR N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • EMKR Semiconductors
  • Sector
  • PRPO Industrials
  • EMKR Technology
  • Exchange
  • PRPO Nasdaq
  • EMKR Nasdaq
  • Market Cap
  • PRPO 8.8M
  • EMKR 9.8M
  • IPO Year
  • PRPO N/A
  • EMKR 1997
  • Fundamental
  • Price
  • PRPO $4.69
  • EMKR $1.37
  • Analyst Decision
  • PRPO
  • EMKR Buy
  • Analyst Count
  • PRPO 0
  • EMKR 2
  • Target Price
  • PRPO N/A
  • EMKR $15.00
  • AVG Volume (30 Days)
  • PRPO 5.6K
  • EMKR 1.6M
  • Earning Date
  • PRPO 08-15-2024
  • EMKR 08-06-2024
  • Dividend Yield
  • PRPO N/A
  • EMKR N/A
  • EPS Growth
  • PRPO N/A
  • EMKR N/A
  • EPS
  • PRPO N/A
  • EMKR N/A
  • Revenue
  • PRPO $15,812,000.00
  • EMKR $89,700,000.00
  • Revenue This Year
  • PRPO $75.18
  • EMKR N/A
  • Revenue Next Year
  • PRPO N/A
  • EMKR $2.05
  • P/E Ratio
  • PRPO N/A
  • EMKR N/A
  • Revenue Growth
  • PRPO 61.64
  • EMKR 511.83
  • 52 Week Low
  • PRPO $4.65
  • EMKR $0.78
  • 52 Week High
  • PRPO $8.99
  • EMKR $9.50
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 34.21
  • EMKR 57.76
  • Support Level
  • PRPO $4.73
  • EMKR $1.22
  • Resistance Level
  • PRPO $5.14
  • EMKR $1.47
  • Average True Range (ATR)
  • PRPO 0.34
  • EMKR 0.16
  • MACD
  • PRPO -0.02
  • EMKR 0.05
  • Stochastic Oscillator
  • PRPO 31.40
  • EMKR 69.57

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About EMKR EMCORE Corporation

EMCORE Corp is a provider of sensors and navigation systems for the aerospace and defense market. The company operates in one reporting segment, Inertial Navigation, whose product technology categories include: (a) FOG, (b) QMEMS, (c) RLG, in each case which serve the aerospace and defense market. The company operates geographically in United States and Canada, which is the key revenue generator; Asia; Europe; and Other.

Share on Social Networks: